Last updated: 2026-10-12 08:17:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Alcon Inc. (ALC) operates in the -- sector and is listed on NYSE. The stock is currently priced at $64.10, with a market capitalization of $30.99B and a P/E ratio of 70.43. Over the past 52 weeks, its price has ranged from $61.84 to $87.64. This page covers its latest market performance, valuation, price trends and company information.
$30.99B | |
$64.79 | |
$101.10 | |
$2.50 | |
$64.11 | |
753.00 | |
1.84M | |
70.43 | |
$87.64 | |
$61.84 | |
-- | |
-- |
Alcon Inc. (ALC) is trading at $64.10 in pre-market trading as of 2026-10-12 08:03:00, down 0.02% ($0.01) from the previous close of $64.11
Pre-market trading shows how investors are pricing ALC before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.
Over the past seven days, Alcon Inc. (ALC) moved from $63.94 to $64.10, representing a gain of 0.25% ($0.16).
The stock traded between $62.43 and $64.82 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.
The average daily volume was 1.62 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 8.8%
ALC is currently trading at $64.10, placing it 8.8% of the way from its 52-week low of $61.84 to its 52-week high of $87.64. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
| Employees | 25942 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Alcon Inc. (ALC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.